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Do you remember the sickly kid in your class from
elementary school? I do. No matter what was going
around, he caught it. Even when I was six years old, I
remember wondering why he was sick more than
anybody else. This basic question of variability in suscep-
tibility to infectious disease is what motivated a recent
study by Khor et al. The ‘‘case’’ samples in their case-
control genetic-association study included groups of
people from various parts of the world who had bacter-
emia, tuberculosis, or severe malaria. Their study focused
on variation in CISH, which encodes a suppressor of cyto-
kine signaling, particularly the proinﬂammatory inter-
leukin-2 (IL-2). Variation in CISH was reproducibly associ-
ated with susceptibility to all three infections. Functional
studies support the role of CISH in governing variation in
susceptibility to infection; peripheral blood mononuclear
cells (PBMC) from subjects carrying the risk allele at a SNP
in the CISH promoter expressed less CISH in response to
IL-2 stimulation than did PBMCs from people with the
major allele. The authors raise the idea that, rather than
treating infections with standard antibiotics, perhaps
tweaking this branch of the immune response might be
a way to treat a diverse spectrum of infectious disease by
helping the body help itself.
Khor et al. CISH and susceptibility to infectious diseases.
NEJM 362, 2092–2100.
Treatment for a1-Antitrypsin-Deﬁciency-Associated
Liver Disease
a1-antitrypsin deﬁciency affects two major organ systems:
the lungs and the liver. The chronic obstructive pulmo-
nary disease phenotype is due to a deﬁciency for a1-anti-
trypsin activity and is managed by augmentation of the
protein via infusion. In patients with the most common
Z mutation (ATZ), this therapy has no effect on liver
disease, because it is the result of a toxic gain of function
in which the mutant protein aggregates and causes liver
damage. Because aggregated ATZ is at least partially
degraded through the autophagic pathway, Hidvegi
et al. explored whether they could further stimulate this
response pharmacologically by using the autophagy stim-
ulator carbamazepine. In cell culture, carbamazepine
reduced levels of soluble and insoluble ATZ by stimulating
intracellular degradation of the protein, an effect that was
not observed in cells that lack an intact autophagy1Department of Human Genetics, Emory University School of Medicine, Atlan
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trypsin deﬁciency, carbamazepine reduced ATZ levels and
hepatic ﬁbrosis. Carbamazepine is safe for use in humans,
so this suggests an intervention for a1-antitrypsin-deﬁ-
ciency-associated liver disease and could serve as a model
for treatment of human disease due to protein aggrega-
tion.
Hidvegi et al. An autophagy-enhancing drug promotes degra-
dation of mutant a1-antitrypsin Z and reduces hepatic ﬁbrosis.
Science Express. Published online June 3, 2010. 10.1126/
science.1190354.
CFTR Inﬂuences Birth Rate in Fertile Men
Genetic variation in CFTR is classically associated with
cystic ﬁbrosis (CF), but the range of phenotypes associated
with CFTR is broad—and getting broader. For one, the
typical pulmonary phenotype can vary quite widely in
severity, and mutations in CFTR have even been reported
in people with a diagnosis of chronic rhinosinusitis.
Another class of phenotypes attributed to CFTR relates
to male infertility. Males with classic CF are infertile, but
a majority of men with isolated congenital absence of
the vas deferens also carry mutations in CFTR and are
infertile. Because there is a spectrum of phenotypes asso-
ciated with CFTR variation, Kosova et al. wanted to know
whether even milder CFTR variation could inﬂuence male
fertility. They measured the inﬂuence of the M470V CFTR
polymorphism on fertility in healthy Hutterite men,
a population in which contraceptive use is limited and
large families are desired. Couples in which the man
was homozygous for the Met470 allele had signiﬁcantly
lower birth rates and, on average, took longer to achieve
each birth. The Met470 allele is the ancestral allele, and
it predominates in most of Africa. In other populations,
the derived Val470 allele reaches a frequency as high as
80%–90%, suggesting that it could be under positive
selection, possibly because of its association with a relative
increase in fertility.
Kosova et al. The CFTR Met 470 allele is associated with
lower birth rates in fertile men from a population isolate.
PLOS Genetics. Published online June 3, 2010. 10.1371/jour-
nal/pgen.1000974.
Evolution Shaped by Altitude
The Tibetan people are physiologically adapted to the
high altitudes in which they have lived for thousands ofta, GA 30322, USA
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years and are less susceptible to chronic mountain sick-
ness. The typical reaction to high altitude is characterized
by high hemoglobin levels and excess production of red
blood cells and is associated with pulmonary hyperten-
sion, risk of stroke, and poor pregnancy outcomes,
features that implicate high altitude as an environmental
selective force. By looking for genetic signatures of selec-
tion, two groups recently sought the genetic variation
that has conferred high-altitude adaptation to Tibetans.
Using different statistical approaches, both groups
combed through genetic variation in Tibetan populations
and compared it to that of highly related Lowland Asian
populations. Beall et al. zero in on EPAS1, which encodes
a transcription factor that regulates red blood cell produc-
tion. The same gene is implicated by Simonson et al., as is
an upstream regulator of EPAS1 function, EGLN1. Both
groups demonstrate that certain positively selected
Tibetan alleles in these genes are associated with lower
hemoglobin concentrations, relating the genetic variation
back to the physiological adaptation observed in
Tibetans.
Beall et al. Natural selection on EPAS1 (HIF2a) associated
with low hemoglobin concentration in Tibetan highlanders.
PNAS Early Edition. Published online June 7, 2010. 10.1073/
pnas.10024431074 The American Journal of Human Genetics 87, 3–5, July 9, 2010Simonson et al. Genetic evidence for high-altitude adaptation
in Tibet. ScienceExpress. Published online May 13, 2010.
10.1126/science.1189406.FMRP Controls Neural Stem Cell Proliferation in Flies
The fragile X mental retardation protein, FMRP, inﬂuences
synaptic plasticity by regulating local protein synthesis at
the synapse. Experiments in in vitro model systems
suggest that FMRP also has a hand in neuron production
in the brain. Callan et al. now provide detailed in vivo
data in Drosophila that—early in brain development—
FMRP controls the reentry of quiescent neural progenitors
into the cell cycle. This leads to an increased number of
neurons in the larval brain of dFmr1mutant ﬂies, a change
that persists in adults. Although this increase in neuron
number is not large enough to cause a striking difference
in brain size between mutant and wild-type ﬂies, it is inter-
esting to note that several reports indicate that certain
parts of the brain are larger in children with autism,
a behavioral phenotype that is often a part of the fragile
X syndrome phenotype.
Callan et al. Fragile X protein controls neural stem cell prolif-
eration in the Drosophila brain. Human Molecular Genetics.
Published online June 4, 2010. 10.1093/hmg/ddq213.This Month in our Sister JournalsMutational Analysis of GSD III Yields Testing
Implications
The gene for glycogen storage disease type III (GSD III),
AGL, is a 35-exon gene that encodes the glycogen de-
branching enzyme. In some patients, the disease is
restricted to the liver and is designated GSD IIIb, whereas
the majority of patients also have myopathy, designated
as GSD IIIa. Distinguishing between the two subtypes,
which can be important for patient management and
monitoring, has traditionally relied on a muscle biopsy
for measurement of enzymatic activity in muscle. In order
to get a better handle on the mutational heterogeneity
associated with this disorder, Goldstein et al. sequenced
the complete AGL gene in 32 patients with GSD III and
did targeted sequencing in two additional patients. They
report 38mutations that, together with the published liter-
ature on GSD III, conﬁrms themutational heterogeneity of
this disease and supports full-gene sequencing for identiﬁ-
cation of the causative mutations in patients with GSD III.
Their data also conﬁrm that having one copy of either of
two exon 3 mutations is sufﬁcient to restrict disease to
the GSD IIIb subtype, a ﬁnding that should mean that
patients can avoid a muscle biopsy in classifying their
disease.Goldstein et al. Molecular analysis of the AGL gene: Identiﬁ-
cation of 25 novel mutations and evidence of genetic heteroge-
neity in patients with glycogen storage disease type III. Genetics
in Medicine. Published online April 27, 2010. 10.1097/GIM.0-
b013e3181d94eaa.
Modeling Metabolic Syndrome in Flies
Genome-wide association and heritability studies have
begun to tease out the genetic contribution to metabolic
traits, including blood glucose levels, body mass index,
and cholesterol level. And from the environmental angle,
we are barraged with news about the effects of high-fruc-
tose corn syrup, trans fats, and the ‘‘Western diet.’’ What
we really need to understand is how genes and the envi-
ronment together inﬂuence metabolic traits and
contribute to the massive increases in the prevalence of
metabolic syndrome over recent decades, something
that is hard to tease out in human populations. To
simplify this research question, Reed et al. tackled it in
ﬂies. They measured a series of metabolic traits in many
different Drosophila lines that were fed a range of foods.
Diet accounted for far less of the variance in these meta-
bolic traits than did the genetic variance, but when they
took into account the genotype-by-diet interactions,
they could explain a much larger fraction of the pheno-
typic variance in these traits. The genotype-by-diet inter-
actions were sensitive to the type and amount of sugar
in the food, with changes in the sugar concentration
leading to large changes in how much the ﬂies weighed.
Changes to the dietary fat content also inﬂuenced the
metabolic traits, with a high-fat diet leading to increasedphenotypic variance. The authors use these data to specu-
late about the increased prevalence of complex metabolic
traits in the human population by using a threshold
model of liability.
Reed et al. Genotype-by-Diet interactions drive metabolic
phenotype variation in Drosphila melanogaster. Genetics. Pub-
lished online April 12, 2010. 10.1534/genetics.109.113571.The American Journal of Human Genetics 87, 3–5, July 9, 2010 5
